-
Mashup Score: 3The Myeloma Sessions: post-COMy 2021 myeloma patients session - 3 year(s) ago
During the COVID-19 pandemic, myeloma support and advocacy groups were forced to adapt to a new way of working in…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5On-demand - 3 year(s) ago
COMY 2021 – On Demand Please use password COMY2021 to access the on-demand lectures. Lectures are in the order presented in the live program. You can select any lecture from the dropdown on the top left of the window. Scientific program
Source: The 7th COMy World CongressCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Optimizing immunotherapy to improve outcomes in myeloma - 3 year(s) ago
Paola Neri, MD, PhD, University of Calgary, Calgary, AB, Canada, discusses the current strategies to reverse immune deregulation in patients…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Redefining the standard of care in AL amyloidosis - 3 year(s) ago
Artur Jurczyszyn, MD, PhD, Jagiellonian University Medical College, Kraków, Poland, discusses recent data in the AL amyloidosis space that has…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Waldenström’s therapy: what’s on the horizon? - 3 year(s) ago
The future of Waldenström’s macroglobulinemia therapy is bright, with various novel combinations currently under investigation. In this video, Jorge Castillo,…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Impacts of COVID-19 on patients with multiple myeloma - 3 year(s) ago
Gordon Cook, MB ChB, PhD, FRCP(Glas), FRCPath, Leeds Teaching Hospitals NHS Trust, Leeds provides a brief background on the impact…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Registration - 3 year(s) ago
Tue, Jun 8, 2021 5:00 PM – 6:00 PM UTC Join VJHemOnc for an exclusive Myeloma Session, where patient advocates discuss their experiences. We are delighted to be joined by…
Source: register.gotowebinar.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Registration - 3 year(s) ago
Tue, Jun 8, 2021 5:00 PM – 6:00 PM UTC Join VJHemOnc for an exclusive Myeloma Session, where patient advocates discuss their experiences. We are delighted to be joined by…
Source: register.gotowebinar.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0From myeloma precursors to late relapses, where do BiTEs fit? - 3 year(s) ago
Bispecific T-cell engagers (BiTEs) offer a promising immunotherapeutic approach for multiple myeloma. BiTEs link endogenous T-cells to tumor-expressed antigens to…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Mechanisms of resistance in multiple myeloma treatments - 3 year(s) ago
Niels van de Donk, MD, PhD, VU University Medical Center, Amsterdam, Netherlands, discusses mechanisms of resistance to immunotherapy in patients…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
📣 The post-#COMy21 #Myeloma patients session is now available as a podcast! w/ @Mohty_EBMT, @sarah_0875, @JackMAiello, @MyelomaTeacher and @IMFjimMYELOMA 🎧 Listen here: https://t.co/re0xJ0JL0F @VJHemOnc #VJSounds #VJSessions #MultipleMyeloma #MMsm